Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells

Table 2 Variables associated with clinical outcome

Locoregional recurrence-free survival (LRRS)
Univariate		Multivariate
≥10 positive lymph nodes	p = 0.017	≥10 positive lymph nodes	p = 0.020
Low Gal3	p = 0.034	≥10 positive lymph nodes	p = 0.020
Disease-specific survival (DSS)
Univariate		Multivariate
Low Gal3	p = 0.018	Low Gal3	p = 0.003 p = 0.003
Her2 IHC score	p = 0.008	HER2 IHC score
Race	p = 0.030	HER2 IHC score
Overall survival (OS)
Univariate		Multivariate
Low Gal3	p = 0.019	Low Gal3	p = 0.014
Her2 IHC score	p = 0.015	HER2 IHC score	p = 0.001

Gal3 galectin-3, HER2 human epidermal growth factor receptor 2, IHC immunohistochemistry

ISSN: 1465-542X